TrialThe patient2023

Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program.

David P Hudesman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.